Welcome to visit iReach at JP Photonix Tokyo 2024
- 660nm Red VCSEL

660nm Red VCSEL

iReach advantages:
iReach has dedicated years to refining VCSEL technology, particularly in the short wavelength at visible 660nm red.By optimizing the epitaxial structures and component layouts, we have successfully reduced the threshold current and effectively addressed the challenges of carrier confinement in high-temperature environments. This advancement significantly minimizes the optical degradation of our red VCSELs, ensuring reliable performance even under demanding conditions.
Imagine the confidence that your devices can operate steadily at high temperatures—this is the reliability iReach delivers to our customers. As we continue to innovate, our technology will expand into various applications, from healthcare to industrial uses, making everyday products smarter and more efficient.

Market trend:
As awareness of health and wellness grows, low level laser therapy (LLLT) and blood peripheral oxygen saturation (SpO2) sensing technologies are becoming increasingly prominent. This shift represents not just a technological leap but also a health revolution!
In this dynamic landscape, VCSEL technology stands out with its exceptional performance, offering distinct advantages in efficiency and stability compared to traditional edge-emitting lasers and LEDs.

We believe our VCSEL solutions will transform user experiences. Picture health monitoring devices that deliver precise data, empowering you to stay informed about your well-being—this could greatly enhance your quality of life!

If you’re eager to learn more about these exciting technologies, we invite you to visit our booth at the Photonix Tokyo Exhibition from October 29 to 31!
Let’s explore the endless possibilities that lie ahead together!